chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Broke out in rashes/hives on arms.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0176) via an unspecified route of administration in the  left arm on 28Apr2021 at 14:45 (at the age of 32-year-old) as a single dose for COVID-19immunisation. Medical history included blood pressure high. Concomitant medications included ethinylestradiol, norgestimate (SPRINTEC) and loratadine, pseudoephedrine sulfate (CLARITIN-D) both for an unknown indication started on an unknown date. The patient previously took vancomycin (MANUFACCTURER UNKNOWN) on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 07:00, the patient experienced broke out in rashes/hives on arms. Therapeutic measures were not taken as a result of this event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event broke out in rashes/hives on arms was recovered on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
No adverse symptoms noted. Another live vaccine given, just had Varicella, less than 28 days.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 01-APR-2017 the patient was vaccinated with RECOMBIVAX HB for prophylaxis. On 01-APR-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to RECOMBIVAX HB. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA004161: US-009507513-1708USA004162: US-009507513-1708USA003618:
Injection site became very itchy in the morning exactly 1 week after being inoculated. By evening it was a small red rash about 2 inches in diameter. It was hot to touch and itchy. By morning the rash doubled in size and was inflamed. The edges were red and swollen and the inside was more skin colored, closer to white than red. It was very hot touch, felt like burning more than itching. I had a hard time concentrating throughout the day, felt extremely tired and had a headache too. I took Aspirin, acetaminophen and over the counter Benadryl and noticed an improvement in symptoms.
Patient developed dull headache 14 days after the 2nd dose. and was admitted with venous sinus thrombosis on 04/28/21
The day after the second shot, I developed upper right sided chest pain and pressure, lateral to the sternum extending at times to mid-clavicular line. Sometimes it felt deeper than surface.  I do have a scar from my port which was removed in 11/2020 and the location of the pain correlated at times with the scar but not consistently. I thought the pain was sore muscles since I had done some light weight exercises with my arms the morning of the vaccine.  But the pressure aspect of it was different than sore muscles. And I could feel a localized pain when I swallowed or burped, like it was on the inside of my esophagus. The pain didn't seem to hurt with deep breaths. I thought it'd get better if it was related to muscles and the vaccine, but it just seemed to linger.  I tried mylanta to test the esophagus theory and it improved. Then after a few more days of not resolving, I saw doctor. My biggest concern and fear at that visit was breast cancer recurrence. I was envisioning and enlarged node in my chest or lung. Eek! I had had a couple episodes at some point of painful swallowing prior to all this that I recalled in the visit so we opted to do an EGD. He also  prescribed omeprazole which seemed to help.  Had EGD done on 1-27-2020. Normal except for a loose GE junction which wasn't a surprise since I occasionally experience reflux.  I'm seeing my oncologist next week for my usual 3 month visit. Thankfullly the pain has almost resolved. Pressure is no longer there. Feeling way less anxious about cancer recurrence.
Lightheaded nausea swelling headache chills itching. Swelling continues spreading around injection site and is hard as a tick. Sensation of stinging
have gotten Covid; have gotten Covid; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "have gotten Covid".  The lot number for bnt162b2 was not provided and will be requested during follow up.
CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 18:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 99.7 F, 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, and chills. This report was non-serious.
This non-serious spontaneous case, initially received from other health professional (nurse) on 19-Oct-2018, concerns a 64-year-old, adult, female patient. The patient had no relevant medical history. The patient was not taking any medication at the time of vaccination. On 09-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 1.5 ml instead of 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252235, expiry date: 30-Jun-2019]. On 10-Oct-2018, the patient had a migraine episode which might be due to the flu shot (as reported by reporter). On an unspecified date in Oct-2018, the patient also experienced stomach aches and injection site pain. On 15-Oct-2018, the patient was followed up via phone call. It was noted that the patient was much better. The stomach aches were resolved on an unspecified date. Upon the call, the patient confirmed that she only had injection site pain which was persistent at that moment of the call. At the time of this report, the event migraine was resolving, stomach ache had resolved but the event injection site pain had not resolved. This case (201804665) was linked to the source case 201804657 due to the same reporter.
unopened ADACEL and TUBERSOL as well as punctured TUBERSOL, exposed to 64 F for 24 hours, with no reported adverse event; Initial information received on 23-Feb-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient with unknown demographics who had unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] and while treated with TUBERCULIN TEST [TUBERSOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection dosage unknown (lot - C5841AB, 17-Jan-2023)for unknown indication.  On an unknown date, the patient received a  dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE with unknown dosing lot U7283AA via unknown route in unknown administration site for immunization.  On an unknown date the patient had unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event (product temperature excursion issue) (unknown latency) following the first dose intake and (unknown latency) following the last dose intake of TUBERCULIN TEST.  On an unknown date the patient developed a non-serious unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event (product temperature excursion issue) (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (unopened ADACEL and TUBERSOL as well as punctured TUBERSOL, exposed to 64 F for 24 hours, with no reported adverse event).  At time of reporting, the outcome was Unknown for the event unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age. On 11-JUN-2013 the patient was vaccinated with oral ROTATEQ (lot # H011439, expired date 01-DEC-2013), route, dose and frequency unspecified. The oral ROTATEQ was improperly stored at 8.5 degrees C. -9.1 degrees C for 720 hours. There was no adverse effect reported. The outcome of the patient was unknown. This is one of several reports received from the same source. Additional information has been requested.
Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "65 YO male w/ history of pancreatitis, tobacco, alcohol use, HIV presented with abdominal pain. Found to be COVID 19 positive.labs reveal mildly elevated lipase with imaging finding concerning for pancreatitis.  During his stay, he was placed NPO for bowel rest. He tolerated slow diet advancement afterwards. His respiratory status was stable. Strict return precaution given. "
Flu like symptoms, light headed, clogged ears, swollen neck and face, sore eyes, sore throat (first day) , feeling spacey
Body aches; Fever; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PAIN (Body aches), PYREXIA (Fever), HEADACHE (Headache) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Headache, Fever, HYPOtension,  Body ache, fatigue, Vagal response 3 minutes after receiving vaccine, low grade fever 99.6  Narrative:
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 59-year-old female patient who received SHINGRIX for prophylaxis. On 14th July 2018, the patient received the 1st dose of SHINGRIX. On 14th July 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm and injected limb mobility decreased. On 15th July 2018, the patient experienced nausea, fever, dizziness and influenza-like symptoms. On 16th July 2018, the outcome of the pain in arm, injected limb mobility decreased, nausea, fever, dizziness and influenza-like symptoms were recovered/resolved. The reporter considered the pain in arm, injected limb mobility decreased, nausea, fever, dizziness and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: On Saturday, the patient received SHINGRIX on her arm which became sore the same day and she had difficulty raising it. The next day, she awoke with flu like symptoms which included fever, nausea and dizziness. All the events were resolved on Monday and she was able to go to work. The patient reported all these symptoms to the pharmacist who would also report to VAERS. The reporter did not consent to follow-up.
Post vaccine approx 10-15 minutes later pt started feeling funny, she developed rash, dry mouth and felt like she had a hard time swallowing which lasted several hrs, she was nauseated. Symptoms lasted 24 hrs then she felt ok.
Extreme back pain, general feeling of severe illness, weakness with inability to walk unaided, near collapse.
Within one hour of the HepB vaccine, our daughter was extremely tired, didn't nurse and spit up bright yellow fluid. We went to hospital emergency room the same evening.
Pain on left side especially in her neck swelling at her left clavicle painful to touch; Pain on left side especially in her neck swelling at her left clavicle painful to touch; Pain on left side especially in her neck swelling at her left clavicle painful to touch; Pain on left side especially in her neck swelling at her left clavicle painful to touch; This is a spontaneous report from a contactable nurse (patient herself). A 58-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL3303, expiration date was unknown), intramuscularly in the left arm on 27Jan2021 at 12:30 at a single dose for COVID-19 immunization. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142, expiration date was unknown) on 06Jan2021 at 12:45 AM, intramuscularly in the left arm for COVID-19 immunization. The patient had no medical history. The patient had no known drug allergies (NKDA). There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Jan2021 at 06:00 AM, the patient experienced pain on left side especially in her neck swelling at her left clavicle painful to touch, which was assessed as non-serious. The patient did not receive any treatment for the adverse event. The patient was not recovered from the event.
1 dose cause some hand pain and body pain During 2 dose slight fever on the day of vaccination taken , headache and severe body pain
Erythema Multiforme on both hands and arms.  Red bumps run up to about mid-upper arm on both sides.  Started Prednisone 10mg and Valacyvlovir 500mg on June 30th.  Erythema  Multiforme mostly resolved by July 8, 2021
Lost sense of taste and smell; Started to feel numb; Lost sense of taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost sense of taste and smell), HYPOAESTHESIA (Started to feel numb) and ANOSMIA (Lost sense of taste and smell) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced AGEUSIA (Lost sense of taste and smell), HYPOAESTHESIA (Started to feel numb) and ANOSMIA (Lost sense of taste and smell). At the time of the report, AGEUSIA (Lost sense of taste and smell), HYPOAESTHESIA (Started to feel numb) and ANOSMIA (Lost sense of taste and smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  Treatment information was not provided.
I got shingles's vaccine/shingles's/suspected vaccination failure; shingles's; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient received 1st dose of Shingles vaccine and that hurt bad, refer case US2021AMR175889. The patient stated that the 2nd dose was like charm shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR175889:Same reporter
Received vaccines on 7/13/09. Family contacted health department on 8/3/09 stating that child had a rash that began early am on 8/3/09 after several days of fever. Fever began 7/20/09 but as of 8/3/09 has resolved. Appetite decreased but taking fluids. Sleeping poorly, easily irritated. Family thinks symptoms might be related to immunizations.  Family states that rash is disappearing as of this afternoon. Family called PHD on 8/4/09 stating that child is fretfull, crying and slept poorly last night. States child is walking but favors R leg as if it hurts.  Advised to seek medical attention
Pt recv vax on 2/17/99; on 2/18/99 pt exp joint pain, malaise, painful/swollen lymph nodes in neck
ActHib reconstituted with Sterile water instead of the 0.4% saline diluent and administered to the patient/no AE; Initial information received on 20-Jan-2020 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a patient of an unknown demographics who received HIB (PRP/T) VACCINE [ACT-HIB] which was reconstituted with sterile water instead of the 0.4% saline diluent (lot number, expiry date, route and site of administration were not reported) on an unknown date.  Medical history, concomitant therapy, medical treatment, vaccination and family history were not provided.  It was a actual medication error due to wrong solution used in drug reconstitution.  At the time of this report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.
I had headache, sinus congestion, and coughing. These lasted for about 2 weeks but the cough lasted for about a month. On Jan 18th, I tested positive for COVID-19.
I had excruciating pain during the injection, which progressively worsened afterward reaching 10/10 L shoulder pain within several hours of the injection. The L shoulder pain was so bad that I could not sleep that night, and the L shoulder pain was unrelieved with OTC Tylenol or Ibuprofen. I also noticed a new swollen lymph node under my left armpit the next morning. The L shoulder pain slightly decreased within 48 hours, but I have continued to have limited ROM of my left shoulder, a steady achey pain of my L shoulder, popping and crunching of my L shoulder with movement of my L shoulder, and difficulty abducting or flexing my L arm past 90 degrees since the injection. 2 weeks post-injection I saw an orthopedist who said my symptoms were caused from the vaccine injection and known as SIRVA (shoulder injury related to vaccine administration). He said I was injected too high, leading to injection of the vaccine material into my subacromial/subdeltoid bursa, causing persistent inflammation of the soft tissue leading to bursitis. He had to perform an US guided Toradol injection to attempt to calm down the inflammation caused from the injection.  I have a 4-week follow up with the orthopedist in April. He indicated that an MRI may be required to further evaluate my shoulder.
Aside from arm soreness and flu-like symptoms which lasted one day, I had no adverse events after the vaccine.   Two months after the vaccine, I noticed that my right eyelid was drooping. About six days later, I thought my right cheek near my eye looked flatter than normal. The doctor's office told me to go to the emergency room, which I did. That was  on 6/24/2021. No treatment was required. CT Scan results listed below in Item 19.  On 9/1/2021 I followed up with a neurologist, Dr.  She noted that when I move my eyes to the left, my right eyelid partially closes. She ordered two imaging tests. These were done on 09/23/2021. Results are listed below at the end of Item 19.
Just a sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administration date 12Apr2021 10:00 (Batch/Lot number: unknown) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ATORVASTATIN. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "recovered" (2021), described as "Just a sore arm". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: No covid prior vaccination. No covid tested post vaccination. No known allergies. Facility where the most recent COVID-19 vaccine was administered: Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information was expected.
Headache that started the day after on Thursday, migraine on Friday, persistent headaches daily since the vaccine
I experienced chronic hives, I have had hives everyday since September 22nd and wheezing.